Trials / Completed
CompletedNCT02724098
Bioavailability of Subcutaneous Dexmedetomidine
Bioavailability of Subcutaneously Given Dexmedetomidine in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Turku University Hospital · Other Government
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the pharmacokinetics of subcutaneously administered dexmedetomidine in healthy volunteers. The absolute bioavailability of subcutaneously administered dexmedetomidine will be calculated. In addition, the investigators will report the effects of subcutaneously administered dexmedetomidine on plasma catecholamine levels, vital signs such as systemic blood pressure, heart rate and sedation. The investigators will also monitor the local and systemic safety and tolerability of subcutaneously administered dexmedetomidine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-05-01
- Completion
- 2017-05-01
- First posted
- 2016-03-31
- Last updated
- 2017-09-12
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT02724098. Inclusion in this directory is not an endorsement.